Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight – Eli Lilly

Written by

admin

in

  1. Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight  Eli Lilly
  2. Eli Lilly’s Zepbound, on top of immunology drug, helped reduce psoriatic arthritis symptoms  statnews.com
  3. Tirzepatide Added to Ixekizumab Improves Outcomes in Patients With PsA  Medical Professionals Reference
  4. Eli Lilly and Co’s combination therapy for weight loss shows remarkable efficacy, accelerating the expansion of its immunological disease treatment portfolio.  富途牛牛
  5. Zepbound And Taltz Combo Bolsters Lilly’s Co-Morbidity Plans  Citeline News & Insights

Continue Reading

More posts